Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Microembolic Signals and Serum Markers of Neuronal Damage During Transcatheter Aortic Valve Implantation.

This study has been completed.
Sponsor:
Information provided by:
Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01237743
First received: November 9, 2010
Last updated: March 14, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):